Hawaii has secured a $700 million settlement with the manufacturers of Plavix following a lawsuit alleging they concealed for years the drug's ineffectiveness and potential danger for individuals of East Asian or Pacific Islander descent, a risk that the FDA later required to be disclosed with a boxed warning.
An Illinois Court Ruling Underscores How Intent and Knowledge Factor Into False Claims Act Liability for Pharmacy Reimbursement Submissions
Legislation aims to enhance health care access by allowing Medicare reimbursement for pharmacist services in rural areas, improving patient care and convenience.
Missteps in prescribing and counseling can escalate into catastrophic harm and significant financial liability.
Lawmakers weigh cost concerns, clinical outcomes, and regulatory barriers as access to these medications evolves.
Case highlights the importance of careful cocumentation.
The law has support from patients, health care providers, pharmacists, and the largest health insurance provider in the state.
The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.
A pharmacist's termination raises critical questions about staffing policies, patient safety, and ethical obligations in healthcare. Explore the ongoing legal battle.
In March, Utah became the first state to completely ban fluoridation.
Failure to quickly notify patients could result in significant harm.
Published: August 19th 2025 | Updated:
Published: November 24th 2025 | Updated:
Published: October 28th 2025 | Updated:
